CURRENTLY NOT HIRING / RECRUITING
CanVirex is a spin-off from the Heidelberg University Hospital, founded in 2017 in Basel, Switzerland. The company develops novel immunotherapeutics for the treatment of cancer and has recently committed to using its unique technology to develop a vaccination for protection against COVID-19.
CanVirex and Heidelberg University Hospital have signed a strategic collaboration agreement for the research and clinical development of measles-vectored therapeutics. The Heidelberg University Hospital offers a unique infrastructure for swift clinical translation of our most promising drug candidates. CanVirex has also forged strategic collaborations with key industry partners for GMP manufacturing and commercialization of our products. CanVirex collaborates with the DZIF (German Center for Infection Research) for the development of the COVID-19 vaccine.
Prof. Dr. Guy Ungerechts, the scientific founder of the company, has dedicated his scientific career to explore virus-based cancer therapeutics. Dr. Ungerechts and his scientific team at the Heidelberg University Hospital and the German Cancer Research Center provide extensive technology know-how required for safe and successful clinical development.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Malzgasse 9, Basel,basel-Stadt 4052,switzerland
- Phone
- +41 61 515 0775
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- canvirex.com
- HQ
- Basel, Basel-Stadt
Canvirex Questions
Canvirex's helpline number is +41 61 515 0775
Canvirex's website is canvirex.com
Canvirex's LinkedIn profile is https://ch.linkedin.com/company/canvirex
Canvirex has
5 employees.
View email and phone details for 5
employees at Canvirex.
Canvirex's industry is
Biotechnology Research
Canvirex's top competitors are
Bright Peak Therapeutics,
Bioversys Ag,
Versameb Ag,
Cellestia Biotech,
Celonic Group,
Allegria Therapeutics,
Esocap Ag,
Nouscom,
Amyra Biotech Ag,
Ymmunobio.
Canvirex's categories are Biotechnology Research
Canvirex's founding year is 2017
